The American Society of Addiction Medicine (ASAM) and the American Academy of
Addiction Psychiatry (AAAP) developed this Clinical Practice Guideline on the Management
of Stimulant Use Disorder (hereafter referred to as the Guideline) to provide evidence-based
strategies and standards of care for the trea...
The VA and DoD Evidence-Based Practice Work Group (EBPWG) was established and
first chartered in 2004, with a mission to advise the VA/DoD Health Executive
Committee “on the use of clinical and epidemiological evidence to improve the health of
the population . . .” across the Veterans Health Administ...
This guideline covers diagnosing and managing epilepsy in children, young people and adults in primary and secondary care, and referral to tertiary services. It aims to improve diagnosis and treatment for different seizure types and epilepsy syndromes, and reduce the risks for people with epilepsy.
MHR...
The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.
MHRA advice o...
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable inj...
Dolor Crónico/clasificación,
Dolor Crónico/tratamiento farmacológico,
Dolor Crónico/prevención & control,
Antidepresivos/uso terapéutico,
Marihuana Medicinal/uso terapéutico,
Analgésicos Opioides/uso terapéutico,
Benzodiazepinas/uso terapéutico,
Anticonvulsivantes/uso terapéutico,
Anestésicos Locales/uso terapéutico,
Corticoesteroides/uso terapéutico,
Terapia por Acupuntura
Taenia solium is a zoonotic tapeworm found globally but with particularly high transmission and hyperendemnicity in parts of Latin America, South and South-East Asia and sub-Saharan Africa. Depending on its life cycle, it causes two distinct presentations in humans: taeniasis and (neuro) cysticercosis. A...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de
las personas con epilepsia....
La epilepsia es una condición neurológica caracterizada por “crisis de epilepsia” recurrentes y no provocadas por desencadenantes inmediatos identificables. La “crisis de epilepsia” es la manifestación clínica de una descarga anormal y excesiva de un grupo de neuronas cerebrales. La epilepsia...
El objetivo de esta GPC es mejorar la atención preventiva, terapéutica y rehabilitadora a las personas con trastorno límite de la personalidad (TLP) en los dispositivos asistenciales del Sistema Nacional de Salud (SNS), en particular en los servicios especializados de salud mental. También se pretend...
Trastorno de Personalidad Limítrofe/psicología,
Trastorno de Personalidad Limítrofe/terapia,
Trastorno de Personalidad Limítrofe/tratamiento farmacológico,
Factores de Riesgo,
Vías Clínicas/organización & administración,
Antipsicóticos/uso terapéutico,
Anticonvulsivantes/uso terapéutico,
Antidepresivos/uso terapéutico,
Ansiolíticos/uso terapéutico,
Ácidos Grasos/uso terapéutico,
Naloxona/uso terapéutico,
Grupos de Autoayuda
